Vestnik dermatologii i venerologiiVestnik dermatologii i venerologii0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov112910.25208/vdv1129Research ArticleRecommendations Russian Society of Dermatovenerologists and Cosmetologists
for systemic treatment of psoriasis during the pandemic COVID-19KubanovAlexey A.<p>Dr. Sci. (Med.), Prof., Corresponding Member of the Russian Academy of Sciences, Director</p>alex@cnikvi.ruBakulevAndrey L.<p>Dr. Sci. (Med.), Prof., Head of the Department of Dermatology and Cosmetology</p>info@sarderma.ruhttps://orcid.org/0000-0002-1450-4942KokhanMuza M.<p>Dr. Sci. (Med.), Prof., Head of the Scientific Clinical Department of Dermatology</p>alex@cnikvi.ruOlisovaOlga Yu.<p>Dr. Sci. (Med.), Prof., Head of the V.A. Rakhmanov Department of Skin and Venereal Diseases</p>alex@cnikvi.ruSamtsovALexey V.<p>Dr. Sci. (Med.), Prof., Head of the Department of Skin and Venereal Diseases</p>alex@cnikvi.ruSokolovskiyEvgeny V.<p>Dr. Sci. (Med.), Prof., Head of the Department of Dermatology and Venereology with a Hospital</p>alex@cnikvi.ruKhairutdinovVladislav R.<p>Dr. Sci. (Med.)., Assoc. Prof., Assoc. Prof. of the Department of Skin and Sexually Transmitted Diseases</p>alex@cnikvi.ruKhobeishMarianna M.<p>Cand. Sci. (Med.), Assoc. Prof. Department of Dermatology and Venereology with a Hospital</p>alex@cnikvi.ruAll-Russian Public Organization “Russian Society of Dermatovenerologists and Cosmetologists”020820209629132804202012052020Copyright © 2020, Kubanov A.A., Bakulev A.L., Kokhan M.M., Olisova O.Y., Samtsov A.V., Sokolovskiy E.V., Khairutdinov V.R., Khobeish M.M.2020<p style="text-align: justify;">Below you will find the analysis of the first published data and international clinical recommendations for the systemic treatment of patients with moderate and severe psoriasis in the context of the COVID-19 pandemic in different countries (France, Italy, USA, Spain, and Germany).</p>PsoriasisCOVID-19systemic therapybiologicalsпсориазCOVID-19системная терапиягенно-инженерные биологические препараты[European Commission. Novel coronavirus 2019-nCoV. URL: https://ec.europa.eu/health/coronavirus_en.][FDA. Novel coronavirus (2019-nCoV) URL: https://www.fda.gov/emergency-preparedness-and response/mcm-issues/novel-coronavirus-2019-ncov][Кубанова А. А., Кубанов А. А., Знаменская Л. Ф., Чикин В. В., Бакулев А. Л., Хобейш М. М. и др. Псориаз. В кн.: Федеральные клинические рекомендации. Дерматовенерология, 2015: Болезни кожи. Инфекции, передаваемые половым путем. 5-е изд., перераб. и доп. М.: Деловой экспресс, 2016: 415—470. [Kubanova A.A., Kubanov A.A., Znamenskaya L.F., Chikin V.V., Bakulev A.L., Khobeish M.M., etc. Psoriasis. In: Federal clinical guidelines. Dermatovenereology, 2015: Skin diseases. Sexually transmitted infections. 5th ed., reprint. and add. M.: Business Express, 2016: 415—470 (Russia).]][Shah P., Zampella J. G. Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic. 2020 Apr 9. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2020.03.056][Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395 (10223): 497—506.][Ma W-T., Yao X-T., Peng Q., Chen D-K. The protective and pathogenic roles of IL-17 in viral infections: friend or foe? Open Biology. 2019; 9 (7): 190109.][Li C., Yang P., Sun Y. et al. IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus. Cell Res. 2012; 22 (3): 528—538.][Price KN et al. COVID-19 and Immunomodulator/Immunosuppressant Use in Dermatology. J Am Acad Dermatol. 2020 Mar 26. pii: S0190-9622(20)30466-7. doi: 10.1016/j.jaad.2020.03.046.][https://evenements-sfd.fr/coronavirus-covid-19/][https://www.sidemast.org/blog/coronavirus][Hruza G. J., Grant-Kels J. M., Van Beek M/J/ at al/ Guidance on the use of biologic agents during COVID-19 outbreak. AAD. 2020.][https://aedv.es/?s=covid][https://aedv.es/coronavirus-los-pacientes-dermatologicos-no-deben-suspender-sus-tratamiento/][Augustin M., von Kiedrowsky R., Korber A. et al. Recommendations for systemic therapy in persons with psoriasis during the pandemic phase of SARS-COV-2 (corona virus). PsoNet, 2020.][Wang T., Du Z., Zhu F. et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020.][Yang J., Zheng Y., Gou X. et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020.][Fang L., Karakiulakis G. Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020.]